
Many of Australia’s top brokers have been busy adjusting their financial models and recommendations again. This has led to the release of a number of broker notes this week.
Three ASX shares that brokers have named as buys this week are listed below. Here’s why their analysts are feeling bullish on them right now:
Aristocrat Leisure Limited (ASX: ALL)
According to a note out of Macquarie, its analysts have retained their outperform rating and $50.50 price target on this gaming technology company’s shares. The broker highlights that Aristocrat is looking into the potential sale of its Plarium and Big Fish digital gaming businesses. Macquarie believes this would be a smart move and could command a sale price of up to US$1.18 billion based on peer valuations and the popularity of its RAID: Shadow Legends game. Macquarie sees the potential sale as a positive and expects it to support a re-rating of its shares. Particularly given that it will allow management to focus more on its core business and growing social casino and real money gaming businesses. The Aristocrat Leisure share price is trading at $43.45 this afternoon.
Domino’s Pizza Enterprises Ltd (ASX: DMP)
A note out of Citi reveals that its analysts have upgraded this pizza chain operator’s shares to a buy rating with a $44.50 price target. The broker has become more positive on the struggling company after it laid out its plans to address its underperformance in the European market. Citi notes that the company’s excessive discounting has cheapened the brand and Domino’s failed to localise its offer. However, it thinks that Domino’s agreement to allow third-party delivery via aggregator services should lead to higher volumes. It also sees potential for the brand to outperform across a European summer that includes Euro 2024 and the Paris Olympics. The Domino’s share price is fetching $36.56 on Wednesday.
Pro Medicus Limited (ASX: PME)
Analysts at Goldman Sachs have reiterated their buy rating on this health imaging technology company’s shares with an improved price target of $136.00. Goldman highlights that Pro Medicus has won five new contracts with a minimum value of $45 million. It notes that this brings the company’s minimum total contract value (TCV) for new sales this financial year to $245 million. Goldman believes this supports its view that the company’s Visage 7 software is an industry leading solution and that Pro Medicus is the incumbent technology leader in radiology and well-placed to take market share. The Pro Medicus share price is trading at $115.28 today.
The post Top brokers name 3 ASX shares to buy today appeared first on The Motley Fool Australia.
Should you invest $1,000 in Aristocrat Leisure Limited right now?
Before you buy Aristocrat Leisure Limited shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Aristocrat Leisure Limited wasn’t one of them.
The online investing service heâs run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
See The 5 Stocks
*Returns as of 5 May 2024
More reading
- Buy ‘one of the highest quality’ growth shares on the ASX 200
- Why you should buy this ‘industry leading’ ASX 200 tech stock
- 5 things to watch on the ASX 200 on Wednesday
- Here are the top 10 ASX 200 shares today
- 4 ASX growth shares to buy to supercharge your portfolio in June
Citigroup is an advertising partner of The Ascent, a Motley Fool company. Motley Fool contributor James Mickleboro has positions in Domino’s Pizza Enterprises and Pro Medicus. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Domino’s Pizza Enterprises, Goldman Sachs Group, Macquarie Group, and Pro Medicus. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Domino’s Pizza Enterprises and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
Leave a Reply